Suppr超能文献

普瑞巴林与昂丹司琼治疗透析患者尿毒症瘙痒的比较:一项前瞻性、随机、双盲研究。

Comparison of pregabalin with ondansetron in treatment of uraemic pruritus in dialysis patients: a prospective, randomized, double-blind study.

作者信息

Yue Ji, Jiao Shoufeng, Xiao Yangfei, Ren Wei, Zhao Tingbao, Meng Jianzhong

机构信息

Department of Spinal Cord Repairing, General Hospital of Jinan Military Area Command, Jinan, Shandong, People's Republic of China.

出版信息

Int Urol Nephrol. 2015 Jan;47(1):161-7. doi: 10.1007/s11255-014-0795-x. Epub 2014 Aug 7.

Abstract

AIM

Pruritus is common among patients with end-stage renal disease undergoing dialysis, and the pathogenesis can be explained by several mechanisms. However, there is no definite evidence supporting them, which limits the relative efficacy of any individual treatment option. In this paper, we aimed to compare pregabalin with ondansetron in treatment of uraemic pruritus (UP) in dialysis patients.

METHODS

In this 12-week prospective, randomized, and double-blind trial, we assessed the efficacy and side effects in UP patients undergoing dialysis. Patients were randomly assigned to receive 12 weeks of 75 mg twice-weekly pregabalin or 8 mg/day ondansetron or a placebo. Visits were scheduled at 0, 2, 4, 6, 8, and 12 weeks after treatment. The severity of pruritus was evaluated using Visual Analogue Scale and modified Duo's VAG Scale. Quality of sleep was evaluated using the Pittsburgh sleep quality index. The effect of UP on health-related quality of life was assessed using the Chinese version of the 12-item short-form (SF-12) general health survey. Baseline laboratory data and demographic characteristics were recorded from patient charts.

RESULTS

Finally, 179 (108 males, 71 females, aged 54.7±11.3 years old) out of the 188 patients completed the 12-week study. Of five patients who stopped pregabalin treatment due to side effects, two patients reported an improvement in nausea and vomiting among those receiving ondansetron. Two patients dropped out for renal transplantation. The 179 patients included 62 cases from the pregabalin group, 60 from the ondansetron group, and 57 from the placebo group. Over the 12 weeks, only pregabalin improved UP significantly. The severity of pruritus was reduced significantly in the pregabalin group compared with the ondansetron and the placebo groups. The final pruritus scores were not different between the ondansetron and the placebo groups. Pruritus absolutely disappeared in two patients following renal transplantation.

CONCLUSIONS

Pregabalin is an effective alternative for treatment of uraemic pruritus. Ondansetron has negligible effect on uremic pruritus and is expensive. A larger sample size may be needed to demonstrate the effect of ondansetron in uraemic pruritus.

摘要

目的

瘙痒在接受透析的终末期肾病患者中很常见,其发病机制可通过多种机制来解释。然而,目前尚无确凿证据支持这些机制,这限制了任何单一治疗方案的相对疗效。在本文中,我们旨在比较普瑞巴林与昂丹司琼治疗透析患者尿毒症瘙痒(UP)的效果。

方法

在这项为期12周的前瞻性、随机、双盲试验中,我们评估了接受透析的UP患者的疗效和副作用。患者被随机分配接受为期12周的每周两次75毫克普瑞巴林、每日8毫克昂丹司琼或安慰剂治疗。在治疗后的0、2、4、6、8和12周安排随访。使用视觉模拟量表和改良的杜氏VAG量表评估瘙痒的严重程度。使用匹兹堡睡眠质量指数评估睡眠质量。使用中文版12项简短健康调查问卷(SF - 12)评估UP对健康相关生活质量的影响。从患者病历中记录基线实验室数据和人口统计学特征。

结果

最终,188例患者中有179例(108例男性,71例女性,年龄54.7±11.3岁)完成了为期12周的研究。在因副作用停止普瑞巴林治疗的5例患者中,有2例在接受昂丹司琼治疗的患者中报告恶心和呕吐有所改善。2例患者因肾移植退出研究。这179例患者中,普瑞巴林组62例,昂丹司琼组60例,安慰剂组57例。在12周内,只有普瑞巴林显著改善了UP。与昂丹司琼组和安慰剂组相比,普瑞巴林组瘙痒的严重程度显著降低。昂丹司琼组和安慰剂组的最终瘙痒评分没有差异。2例患者肾移植后瘙痒完全消失。

结论

普瑞巴林是治疗尿毒症瘙痒的有效替代药物。昂丹司琼对尿毒症瘙痒的作用可忽略不计且价格昂贵。可能需要更大的样本量来证明昂丹司琼在尿毒症瘙痒中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验